Beware of Rhodamine-B: Several States in India Implement Ban on Artificial Food Coloring Agents

▴ Several States in India Implement Ban on Artificial Food Coloring Agents
Moving forward, continued vigilance and adherence to regulatory standards are essential in fostering a culture of food safety and well-being nationwide.

In a significant move to safeguard public health, Karnataka, along with several other states, has imposed a ban on the use of artificial coloring agents, including Rhodamine-B, in popular food items such as cotton candy and 'gobi manchurian.' This proactive measure aims to mitigate potential health risks associated with the consumption of these hazardous chemicals.

Health Minister Dinesh Gundu Rao emphasized the severity of the ban, warning of strict consequences for violators. Sellers found using Rhodamine-B face the prospect of imprisonment for up to seven years and hefty fines of up to Rs 10 lakh. The ban stems from growing concerns over the long-term health implications of consuming snacks containing artificial colors, which have been linked to various health issues, including cancer.

Understanding Rhodamine-B: Rhodamine-B, characterized by its bright pink hue, is a chemical coloring agent commonly used in textiles, cosmetics, and the food industry. Despite its vibrant appearance, Rhodamine-B poses significant health risks to humans, animals, and the environment. It exerts toxic effects on the body, leading to oxidative stress on cells and tissues upon ingestion.

The US National Library of Medicine underlines the detrimental effects of Rhodamine-B consumption, citing its association with liver dysfunction, cancer, and acute poisoning. This synthetic additive, though inexpensive and visually appealing, poses a grave threat to public health.

Expert Insights: Dr. Muralidhar S. Kathalagiri, a Consultant Laparoscopic, Bariatric, and Gastrointestinal Surgeon at SPARSH Hospital, Bangalore, warns against the hidden dangers of synthetic food additives. While food coloring agents enhance visual appeal, they often harbor detrimental effects on health, especially those lacking government approval.

Dr. Kathalagiri highlights the potential health consequences of consuming additives like Rhodamine-B, ranging from allergic reactions to long-term ailments such as cancer and organ damage. As such, awareness of these risks is paramount in making informed dietary choices and prioritizing health and well-being.

Scope of the Ban: The ban on Rhodamine-B extends beyond cotton candy and 'gobi manchurian' to encompass various food items, including chilli oil, sweets, curry powder, and sauces. The Food Safety and Standards Authority of India (FSSAI) mandates strict adherence to regulations governing food additives, prohibiting the use of unauthorized coloring agents.

Permissible Artificial Coloring Agents: According to FSSAI guidelines, only specific artificial coloring agents are permitted for use in food products. These include Ponceau 4R, Carmoisine, Erythrosine (Red), Tartrazine, Sunset Yellow FCF (Yellow), Indigo Carmine, Brilliant Blue FCF (Blue), and Fast Green FCF (Green). Compliance with these regulations ensures the safety and integrity of food products available in the market.

Nationwide Implications: The ban on Rhodamine-B transcends state borders, with Tamil Nadu and Puducherry also implementing stringent measures to curb its use. The recognition of Rhodamine-B as a "cancer-causing chemical" underlines the urgency of adopting preventive measures to protect public health.

Karnataka's decisive action against the use of Rhodamine-B reflects a commitment to safeguarding public health and promoting consumer safety. By prohibiting the use of hazardous artificial coloring agents, authorities aim to mitigate health risks and ensure the integrity of food products. Moving forward, continued vigilance and adherence to regulatory standards are essential in fostering a culture of food safety and well-being nationwide.

Tags : #rhodamineb #ban #artificial #foodcolouring #foodsafety #gobimanchurian

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

02 Apr

DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?

As the healthcare landscape evolves, initiatives like these will determine the future of medical care in the country.

View
01 Mar

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?

The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View
24 Feb

The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing System

The NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary.

View
24 Feb

The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West Africa

Stricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups.

View
21 Feb

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market.

View
19 Feb

Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery Wave

AIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed.

View
19 Feb

Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?

As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change.

View
12 Feb

First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis Specialist

Delayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025